Vanberra Signal

SmartTarget

Curated by Signal

Provides medical image fusion solutions for guiding prostate cancer biopsy and minimally-invasive cancer treatment

Overview

SmartTarget provides medical image fusion solutions for guiding prostate cancer biopsy and minimally invasive cancer treatment. The CE certified SmartTarget system is an image fusion device for guiding targeted, transperineal prostate biopsy. The SmartTarget software offers a single-user workflow in which changes in the shape and position of the prostate between magnetic resonance (MR) and ultrasound images are automatically compensated for.

Key facts

Founded
2015

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of transcription services and solutions to healthcare industries

    Health TechnologyBolton, United Kingdom
  • Digital diagostic assemsnt tool

    Health TechnologyLondon, United Kingdom
  • Digital treatment management tool for providers

    Health TechnologyUnited Kingdom

About SmartTarget

What does SmartTarget do?

SmartTarget provides medical image fusion solutions for guiding prostate cancer biopsy and minimally invasive cancer treatment.

Where is SmartTarget headquartered?

SmartTarget is headquartered in London, United Kingdom.

When was SmartTarget founded?

SmartTarget was founded in 2015.

Which sector is SmartTarget in?

SmartTarget operates in Health Technology.

Who are SmartTarget's competitors?

Companies similar to SmartTarget include Rx SCRIBE, TeamGenie, and StratCare.